Transgenic Medicinal Plants

Comprising 26 chapters, this volume deals with the genetic transformation of medicinal plants. It describes methods to obtain plants resistant to insects, diseases, herbicides, and plants with an increased production of compounds of medicinal and pharmaceutical importance. The plant species included are Ajuga reptans, Anthemis nobilis, Astragalus spp., Atropa belladonna, Catharanthus roseus, Datura spp., Duboisia leichhardtii, Fagopyrum spp., Glycyrrhiza uralensis, Lobelia spp., Papaver somniferum, Panax ginseng, Peganum hamala, Perezia spp., Pimpinella anisum, Phyllanthus niruri, Salvia miltiorrhiza, Scoparia dulcis, Scutellaria baicalesis, Serratula tinctoria, Solanum aculeatissimum, Solanum commersonii, Swainsona galegifolia, tobacco, and Vinca minor. The book is of special interest to advanced students, teachers, and researchers in the fields of pharmacy, plant tissue culture, phytochemistry, molecular biology, biomedical engineering, and plant biotechnology in general.

In the mid-eighties, there was a revolution in plant biotechnology. Simple procedures could be used to genetically transform plants. Such transgenic plants will express alien genes, virtually from any organism, provided the genes are flanked by appropriate controlling elements. Soon after this biotechnology became available, there was an awareness that crop plants can serve as manufacturers of high-value medical products. This book provides the molecular and biotechnological background for genetic transformation in plants, as well as updated information about the production of antibodies, antigens and other medical and health products by transgenic plants. The book handles the relevant information in a critical manner by pointing out the risks and problems as well as presenting the outlook for development in this field. It provides a comprehensive and well-balanced treatment of its theme.

There has been tremendous progress in the genetic transformation of agricultural crops, and plants resistant to insects, herbicides,and diseases have been produced, field tested and patented. Transgenic Crops III compiles this information on ornamental, aromatic, medicinal and various other crops. It comprises 26 chapters and is divided into two sections. I. Ornamental, Aromatic and Medicinal Plants: Anthurium, Antirrhinum, Artemisia, Begonia, Campanula, carnation, chrysanthemum, Dendrobium, Eustoma, Gentiana, Gerbera, Gladiolus, Hyoscyamus muticus, Hyssopus officinalis, ornamental Ipomoea, Leontopodium alpinum, Nierembergia, Phalaenopsis, Rudbeckia, Tagetes, and Torenia. II. Miscellaneous Plants: Craterostigma plantagineum, Flaveria bidentis, Moricandia Solanum brevidens, and freshwater wetland monocots. The book is of special interest to advanced students, teachers and research workers in the fields of plant breeding, genetics, molecular biology, plant tissue culture and plant biotechnology in general.

Transgenic Technology Based Value Addition in Plant Biotechnology discusses the principles, methodology and applications of transgenic technologies. With step-by-step methods on genome editing techniques and a range of potential applications, from improving crop yield to increasing therapeutic efficacy, this book is a one-stop reference for plant gene editing technologies. It will be of particular interest to researchers interested in plant biotechnology and plant genetics, as well as agricultural scientists and those concerned with medicinal plants. Includes step-by-step methods to assist students and researchers with genome editing and bioinformatics tools Highlights a number of applications of plant biotechnology, including how to achieve desired traits, such as improved crop yield Discusses principles, methodology and applications of transgenic technologies

In the mid-eighties, there was a revolution in plant biotechnology. Simple procedures could be used to genetically transform plants. Such transgenic plants will express alien genes, virtually from any organism, provided the genes are flanked by appropriate controlling elements. Soon after this biotechnology became available, there was an awareness that crop plants can serve as manufacturers of high-value medical products. This book provides the molecular and biotechnological background for genetic transformation in plants, as well as updated information about the production of antibodies, antigens and other medical and health products by transgenic plants. The book handles the relevant information in a critical manner by pointing out the risks and problems as well as presenting the outlook for development in this field. It provides a comprehensive and well-balanced treatment of its theme.

Volumes 1 and 2 of Transgenic Plants assemble important information on transgenic crops which has appeared scattered in many different publications. These two volumes are a significant milestone in plant/agricultural biology, promote the practical application of recombinant DNA technology, and assist in transforming the agricultural industry.

Plant-based medicines assume a critical part in all societies, and have been fundamental in keeping up wellbeing and battling infections. The distinguishing proof of dynamic standards and their sub-atomic focuses from customary prescription gives a huge chance to sedate advancement. Utilizing present day biotechnology, plants with particular synthetic syntheses can be mass spread and hereditarily enhanced for the extraction of mass dynamic pharmaceuticals. In spite of the fact that there has been noteworthy advance in the utilization of biotechnology, utilizing tissue societies and hereditary change to research and modify pathways for the biosynthesis of target metabolites, there are many difficulties associated with bringing plants from the lab to effective plug development. This book shows the most recent advances in the improvement of restorative medications, including points, for example, plant tissue societies, optional metabolite generation, metabolomics, metabolic building, bioinformatics and future biotechnological bearings. This special review of plants and transgenic systems of extraordinary logical, therapeutic and financial incentive for both industry and the scholarly community covers the entire range from cell culture methods, by means of hereditary designing and auxiliary item digestion up to the utilization of transgenic plants for the generation of bioactive mixes.

The aim of Transgenic Plants: Methods and Protocols is to provide a source of information to guide the reader through a wide range of frequently used, broadly applicable, and easily reproducible techniques involved in the gene- tion of transgenic plants. Its step-by-step approach covers a series of methods for genetically transforming plant cells and tissues, and for recovering whole transgenic plants from them. The volume then moves on to the use of sele- able and reporter markers, positive selection, marker elimination after rec- ery of transgenic plants, and the analysis of transgene integration, expression, and localization in the plant genome. Although contributors usually refer to model plants in most chapters, the protocols described herein should be widely applicable to many plant species. The last two sections are devoted to me- ods of risk assessment and to exploring the current and future applications of transgenic technology in agriculture and its social implications in a case study. Transgenic Plants: Methods and Protocols is divided into six major s- tions plus an introduction, comprising 27 chapters. Part I, the Introduction, is a review of the past, present, and perspectives of the transgenic plants, from the discovery of Agrobacterium tumefaciens as a feasible transformation vector, to its use as a tool to study gene expression and function, and the current and possible future applications of this technology in agriculture, industry, and medicine.